TuHURA Biosciences (NASDAQ: HURA) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHYF, ML, HURA, KANT on Behalf of Shareholders
TuHURA Biosciences (NASDAQ: HURA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $11.00 price target on the stock.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, ML, HURA, KANT on Behalf of Shareholders
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of TuHURA Biosciences, Inc. - HURA